With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...

The global anatomic pathology market is poised for a strong growth trajectory, expected to expand at a CAGR of nearly 8% during the forecast period. This growth is driven by several critical forces, ...

First-and-only test of its kind approved under new European Union regulations expands access to personalized cancer care for patients across the EU This in vitro diagnostic (IVD) assay, which has been ...